On the occasion of the 19th edition of its Global Meeting, the Women’s Forum reveals the results of its annual barometer on gender inequalities, developed in partnership with Ipsos, among a sample of 3,500 people residing within the countries of the G7.
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
Ipsos and AXA publish today the 11th wave of the Future risks report. Conducted among a sample of 19,000 people representative of the national populations within 15 countries in the world and +3,000 risk experts within 50 countries, this study measures and classifies the levels of fear but also the feeling of vulnerability in the face of 25 different life risks.
